Amgen Inc. v. F. Hoffmann-La Roche Ltd., No. 09-1020

In a patent infringement case involving patents relating to the production of the protein erythropoietin using recombinant DNA technology, district court's judgment is vacated in part and remanded where: 1) district court's grant of summary judgment and of judgment as a matter of law (JMOL) to plaintiff-Amgen of no invalidity for obviousness-type double patenting of certain claims of one patent is vacated and remanded for an obviousness-type double patenting analysis of these claims; and 2) district court's grant of JMOL to Roche of non-infringement of one claim of another patent is vacated and remanded for a new trial on infringement of that claim. District court's grant of injunction to Amgen is not disturbed and the court's judgment is affirmed in all other respects.  

Read Amgen Inc. v. F. Hoffmann-La Roche Ltd., No. 09-1020

Appeal from:  United States District Court for the District of Massachusetts
Decided September 14, 2009

Judges

Before Mayer, Clevenger, and Schall, CIrcuit Judges. 
Opinion by Schall, Circuit Judge.   

Counsel

For Appellant:  Lloyd R. Day Jr., David M Madrid, Linda A. Sasaki-Baxley, Jonathon D. Loeb, Stuart L. Watt, Wendy A. Whiteford, Erica S. Olson, Cecilia H. Gonzalez, Margaret D. McDonald, Christiam E. Mammen.

For Appellee: Leora Ben-Ami Thomas F. Fleming, Patricia A, Carson, Christopher T. Jagoe Sr., Howard S. Suh, Lee Carl Bromberg, Timothy M. Murphy, Julia Huston, Daniel Forchheimer, Mathew McFarlane.